NRx Pharmaceuticals Inc. (NASDAQ:NRXP) shares, rose in value on Wednesday, 07/21/21, with the stock price down by -2.03% to the previous day’s close as strong demand from buyers drove the stock to $10.11.
Actively observing the price movement in the last trading, the stock closed the session at $10.32, falling within a range of $9.76 and $10.99. Referring to stock’s 52-week performance, its high was $76.99, and the low was $8.39. On the whole, NRXP has fluctuated by -28.09% over the past month.
Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that NRXP’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium term indicators have put the stock in the category of 100% Sell while long term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of NRXP currently trading nearly -11.68% and -41.89% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 40.57, while the 7-day volatility ratio is showing 17.69% which for the 30-day chart, stands at 13.55%. Furthermore, NRx Pharmaceuticals Inc. (NRXP)’s beta value is 0.00, and its average true range (ATR) is 1.79.
Data on historical trading for NRx Pharmaceuticals Inc. (NASDAQ:NRXP) indicates that the trading volumes over the past 10 days have averaged 10.21 million and over the past 3 months, they’ve averaged 1.31 million. According to company’s latest data on outstanding shares, there are 47.46 million shares outstanding.
Nearly 1.40% of NRx Pharmaceuticals Inc.’s shares belong to company insiders and institutional investors own 1.30% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 94470.0 shares as on May 27, 2021, resulting in a short ratio of 0.93. According to the data, the short interest in NRx Pharmaceuticals Inc. (NRXP) stood at 0.20% of shares outstanding as of May 27, 2021. The stock has fallen by -58.57% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the NRXP stock heading into the next quarter.